Towards evidence-based immunology

David S Khoury¹, Deborah Cromer¹, Bronwyn Bailey¹, Shanchita R Khan¹, Deborah L Burnett^{2

3}, Stephen J Kent^{4

5}, Brian D Rudd⁶, Arnaud Marchant⁷, Tari Turner⁸, Miles P Davenport⁹

Affiliations

¹ Infection Analytics Program, Kirby Institute, UNSW Sydney, Kensington, New South Wales, Australia.
² School of Biomedical Sciences, UNSW Sydney, Kensington, New South Wales, Australia.
³ Cellular Genomics Institute, UNSW Sydney, Kensington, New South Wales, Australia.
⁴ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
⁵ Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
⁶ Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA.
⁷ European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Brussels, Belgium.
⁸ School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
⁹ Infection Analytics Program, Kirby Institute, UNSW Sydney, Kensington, New South Wales, Australia. m.davenport@unsw.edu.au.

PMID: 40457059
DOI: 10.1038/s41590-025-02180-0

Towards evidence-based immunology

David S Khoury et al. Nat Immunol. 2025 Jul.

. 2025 Jul;26(7):980-982.

doi: 10.1038/s41590-025-02180-0.

Authors

David S Khoury¹, Deborah Cromer¹, Bronwyn Bailey¹, Shanchita R Khan¹, Deborah L Burnett^{2

3}, Stephen J Kent^{4

5}, Brian D Rudd⁶, Arnaud Marchant⁷, Tari Turner⁸, Miles P Davenport⁹

Affiliations

¹ Infection Analytics Program, Kirby Institute, UNSW Sydney, Kensington, New South Wales, Australia.
² School of Biomedical Sciences, UNSW Sydney, Kensington, New South Wales, Australia.
³ Cellular Genomics Institute, UNSW Sydney, Kensington, New South Wales, Australia.
⁴ Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.
⁵ Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.
⁶ Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA.
⁷ European Plotkin Institute for Vaccinology, Université libre de Bruxelles, Brussels, Belgium.
⁸ School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
⁹ Infection Analytics Program, Kirby Institute, UNSW Sydney, Kensington, New South Wales, Australia. m.davenport@unsw.edu.au.

PMID: 40457059
DOI: 10.1038/s41590-025-02180-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: M.P.D. and T.T. are co-leads of the Framework for Evidence Evaluation in Vaccine Assessment (FEEVA) initiative. The other authors have no conflicts of interest to declare.

References

1. Cobey, K. D. et al. PLoS Biol. 22, e3002870 (2024). - DOI - PubMed - PMC
1. Baker, M. Nature 533, 452–454 (2016). - DOI - PubMed
1. Suliman, S., Maison, D. P. & Henrich, T. J. Nat. Immunol. 25, 1765–1769 (2024). - DOI - PubMed
1. Espin, E. et al. EBioMedicine 91, 104552 (2023). - DOI - PubMed - PMC
1. Kimmelman, J., Mogil, J. S. & Dirnagl, U. PLoS Biol 12, e1001863 (2014). - DOI - PubMed - PMC

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Towards evidence-based immunology

Affiliations

Towards evidence-based immunology

Authors

Affiliations

Conflict of interest statement

References

LinkOut - more resources

Full Text Sources